The quasi-corporate venturing units of two Danish foundations back the kidney treatment company.

Media company Hearst Corporation takes a 20% stake in the UK-based design intelligence company, and separately one of its corporate venturing unit's portfolio companies raises a $20m round.

BASF Venture Capital invested $2.7m of the total. Oliver Guthmann, investment manager at BASF Venture Capital, said: "We have followed FRX's progress since 2008 and we are excited to take part in its series B round of financing."

Launched in October, the $25m Michigan Investment in New Technology Startups (MINTS) fund invests in companies built from its academics' research as long as an independent venture capital firm leads the round.

Royal DSM invests again in "super-bug" treatment company IQ Therapeutics.

Eight19 targets $8m round in January, following an earlier round in 2010 from Carbon Trust, Rhodia, and Cambridge Enterprise.

The US-based cloud network company wins backing of Cisco alongside Venrock and Benchmark Capital.

Next Media, a Taiwan-based animation company, joins Benchmark Capital and Shasta Ventures backing the US-based games maker.